103 related articles for article (PubMed ID: 22406839)
1. The hinge region in androgen receptor control.
Clinckemalie L; Vanderschueren D; Boonen S; Claessens F
Mol Cell Endocrinol; 2012 Jul; 358(1):1-8. PubMed ID: 22406839
[TBL] [Abstract][Full Text] [Related]
2. The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor.
Haelens A; Tanner T; Denayer S; Callewaert L; Claessens F
Cancer Res; 2007 May; 67(9):4514-23. PubMed ID: 17483368
[TBL] [Abstract][Full Text] [Related]
3. Collocation of androgen receptor gene mutations in prostate cancer.
Buchanan G; Greenberg NM; Scher HI; Harris JM; Marshall VR; Tilley WD
Clin Cancer Res; 2001 May; 7(5):1273-81. PubMed ID: 11350894
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor acetylation sites differentially regulate gene control.
Faus H; Haendler B
J Cell Biochem; 2008 May; 104(2):511-24. PubMed ID: 18022799
[TBL] [Abstract][Full Text] [Related]
5. DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation.
Haelens A; Verrijdt G; Callewaert L; Christiaens V; Schauwaers K; Peeters B; Rombauts W; Claessens F
Biochem J; 2003 Jan; 369(Pt 1):141-51. PubMed ID: 12350223
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions.
Deeb A; Jääskeläinen J; Dattani M; Whitaker HC; Costigan C; Hughes IA
J Clin Endocrinol Metab; 2008 Oct; 93(10):3691-6. PubMed ID: 18697867
[TBL] [Abstract][Full Text] [Related]
7. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
[TBL] [Abstract][Full Text] [Related]
8. Evidence that lack of ligand-binding domain correlates with nuclear distribution of unliganded human androgen receptor and loss of transactivation activity.
Suzuki N; Imai A
Gynecol Endocrinol; 2011 Nov; 27(11):940-3. PubMed ID: 21501000
[TBL] [Abstract][Full Text] [Related]
9. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C
J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969
[TBL] [Abstract][Full Text] [Related]
11. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
[TBL] [Abstract][Full Text] [Related]
12. Ligand binding to the androgen receptor induces conformational changes that regulate phosphatase interactions.
Yang CS; Xin HW; Kelley JB; Spencer A; Brautigan DL; Paschal BM
Mol Cell Biol; 2007 May; 27(9):3390-404. PubMed ID: 17325038
[TBL] [Abstract][Full Text] [Related]
13. Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells.
Dehm SM; Regan KM; Schmidt LJ; Tindall DJ
Cancer Res; 2007 Oct; 67(20):10067-77. PubMed ID: 17942941
[TBL] [Abstract][Full Text] [Related]
14. Involvement of three glutamine tracts in human androgen receptor transactivation.
Harada N; Mitani T; Higashimura Y; Yamaji R; Okamoto K; Nakano Y; Inui H
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):77-84. PubMed ID: 19833203
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
Holterhus PM; Werner R; Struve D; Hauffa BP; Schroeder C; Hiort O
Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):457-63. PubMed ID: 16151980
[TBL] [Abstract][Full Text] [Related]
16. Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome.
Jääskeläinen J; Mongan NP; Harland S; Hughes IA
Hum Mutat; 2006 Mar; 27(3):291. PubMed ID: 16470553
[TBL] [Abstract][Full Text] [Related]
17. The hinge region of the androgen receptor plays a role in proteasome-mediated transcriptional activation.
Tanner T; Claessens F; Haelens A
Ann N Y Acad Sci; 2004 Dec; 1030():587-92. PubMed ID: 15659841
[TBL] [Abstract][Full Text] [Related]
18. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
[TBL] [Abstract][Full Text] [Related]
19. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
20. Diverse roles of androgen receptor (AR) domains in AR-mediated signaling.
Claessens F; Denayer S; Van Tilborgh N; Kerkhofs S; Helsen C; Haelens A
Nucl Recept Signal; 2008 Jun; 6():e008. PubMed ID: 18612376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
